Balentine LLC’s Fresenius Medical Care FMS Stock Holding History

Balentine LLC’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-379	Closed	-$16K	–	416
2020 Q2	$16K	Buy	+379	New	+$15K	﹤0.01%	439
2019 Q4	–	Sell	-258	Closed	-$9K	–	651
2019 Q3	$9K	Buy	258 +87	+51%	+$3.08K	﹤0.01%	362
2019 Q2	$7K	Hold	171	–	–	﹤0.01%	399
2019 Q1	$7K	Hold	171	–	–	﹤0.01%	323
2018 Q4	$6K	Buy	+171	New	+$6.9K	﹤0.01%	327

Other funds holding FMS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

Balentine LLC's FMS Position: Q3 2020 in Review

Balentine LLC sold out of Fresenius Medical Care (FMS) in Q3 2020, closing a stake of 379 shares — an estimated $16K sold.

Balentine LLC first reported a position in FMS in Q4 2018 and held it in 5 quarters. The position peaked at $16K in Q2 2020. 181 funds tracked by Wall St. Rank hold FMS as of Q3 2020.

Balentine LLC reported no remaining Fresenius Medical Care position as of Q3 2020 after selling out during the quarter.
Balentine LLC sold 379 Fresenius Medical Care shares in Q3 2020, an estimated $16K.
Balentine LLC first reported a position in Fresenius Medical Care in Q4 2018 and held it in 5 quarters.
Balentine LLC's Fresenius Medical Care position peaked at $16K in Q2 2020.
181 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.